US Medical Innovations Reports the US FDA’s Clearance of Canady Helios Cold Plasma Ablation System for Soft Tissue Ablation
Shots:
- The US FDA has granted 510k clearance to Canady Helios Cold Plasma (CHCP) System for soft tissue ablation during surgery. The system distribution is anticipated in late 2024
- The CHCP system, comprising the Canady Helios Cold Plasma XL-1000 CP Smart Electrosurgical Generator, Canady Helios Cold Plasma Ablators, Foot Pedal and Trolley Cart, achieves soft tissue ablation by creating a plasma jet for 5-7mins. applied to the microscopic soft tissue surgical margin post-tumor removal surgery
- Furthermore, the results of P-I study (conducted by the JCRI-ABTS team) for cold atmospheric clinical treatment of advanced solid tumors showed favorable safety & efficacy with 80% non-local recurrence rate & 86% overall survival rate
Ref: Businesswire | Image: Businesswire
Related News:- Merit Medical’s SCOUT MD Surgical Guidance System Receives the US FDA’s Approval for the Detection and Treatment of Soft Tissue Cancers
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
